Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Perception Neuroscience

Recent news which mentions Perception Neuroscience

Atai's Clinical Results Of R-Ketamine For Depression: Road To Subcutaneous At-Home Administration
Tickers ATAI JNJ
Tags Psychedelic/Assisted Therapies Management Ketamine Therapy for depression
From Benzinga
atai Life Sciences' Drug Trial For Depression Fails To Deliver Expected Results, Stock Plunges
Tickers ATAI
Tags Market News Perception Neuroscience Cannabis
From Benzinga
Atai's Phase 2 Study For Treatment-Resistant Depression Completes Enrollment, Expects Results Soon
Tickers ATAI
Tags Psychedelics Benzinga Penny Stocks
From Benzinga
Can Ketamine For Depression Be Improved? New Study Will Looks Into Ketamine Analog Arketamine
Tickers ATAI JNJ
Tags Florian Brand Markets Market News
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS